Payment overview · 2025
General Payments
$35.57
2 reported records · 2 companies
Healthcare provider profile · identity verified
Travis Dale Embry, MD
Allopathic & Osteopathic Physicians|Family Medicine · HUNTSVILLE, AR · NPI 1750386876
Verified facts
What the public records show
CMS Open Payments records show Travis Dale Embry, MD received $35.57 in general payments during 2025 across 2 reported records.
Abbott Laboratories accounted for 59.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Otezla.
Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported OTEZLA as an associated drug or biological on 177267 records involving 48600 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Otezla by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $21.32 | 59.9% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $14.25 | 40.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $35.57 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $21.32 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $14.25 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $14.25 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| OTEZLA otezla |
2025 | Otezla | 2024 | 12 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Amgen Inc. Exact reporting entity; no affiliate inference |
2025 | OTEZLA open payments reported associated product |
CMS Open Payments — General Payments 177267 supporting records · 48600 recipient NPIs · example record 1226871616 |
Otezla · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 940 | 192 |
| Lisinopril | Lisinopril | 544 | 115 |
| Omeprazole | Omeprazole | 497 | 110 |
| Gabapentin | Gabapentin | 473 | 91 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 462 | 87 |
| Amlodipine Besylate | Amlodipine Besylate | 451 | 101 |
| Levothyroxine Sodium | Levothyroxine Sodium | 420 | 82 |
| Furosemide | Furosemide | 407 | 81 |
| Pantoprazole Sodium | Pantoprazole Sodium | 389 | 90 |
| Metformin Hcl | Metformin Hcl | 353 | 67 |
| Losartan Potassium | Losartan Potassium | 333 | 75 |
| Potassium Chloride | Potassium Chloride | 300 | 59 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 278 | 34 |
| Eliquis | Apixaban | 259 | 41 |
| Clopidogrel | Clopidogrel Bisulfate | 243 | 47 |
| Hydrochlorothiazide | Hydrochlorothiazide | 220 | 40 |
| Duloxetine Hcl | Duloxetine Hcl | 216 | 32 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 215 | 78 |
| Fluticasone Propionate | Fluticasone Propionate | 210 | 76 |
| Trazodone Hcl | Trazodone Hcl | 196 | 35 |
| Tramadol Hcl | Tramadol Hcl | 193 | 48 |
| Carvedilol | Carvedilol | 174 | 38 |
| Tamsulosin Hcl | Tamsulosin Hcl | 160 | 36 |
| Alendronate Sodium | Alendronate Sodium | 152 | 34 |
| Ezetimibe | Ezetimibe | 151 | 32 |
| Ropinirole Hcl | Ropinirole Hcl | 150 | 32 |
| Sertraline Hcl | Sertraline Hcl | 150 | 29 |
| Oxycodone Hcl | Oxycodone Hcl | 147 | 19 |
| Escitalopram Oxalate | Escitalopram Oxalate | 146 | 27 |
| Meloxicam | Meloxicam | 139 | 43 |
| Metoprolol Succinate | Metoprolol Succinate | 139 | 36 |
| Metoprolol Tartrate | Metoprolol Tartrate | 136 | 28 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 135 | 33 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 134 | 38 |
| Zolpidem Tartrate | Zolpidem Tartrate | 128 | 26 |
| Risperidone | Risperidone | 127 | 13 |
| Prednisone | Prednisone | 125 | 60 |
| Pravastatin Sodium | Pravastatin Sodium | 120 | 23 |
| Alprazolam | Alprazolam | 116 | 15 |
| Clonidine Hcl | Clonidine Hcl | 113 | 35 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 111 | 53 |
| Mupirocin | Mupirocin | 106 | 64 |
| Tizanidine Hcl | Tizanidine Hcl | 102 | 22 |
| Spironolactone | Spironolactone | 100 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 98 | 22 |
| Clonazepam | Clonazepam | 98 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 95 | 14 |
| Glipizide Er | Glipizide | 92 | 18 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 92 | 22 |
| Mounjaro | Tirzepatide | 90 | 18 |
| Doxycycline Hyclate | Doxycycline Hyclate | 85 | 61 |
| Finasteride | Finasteride | 81 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 80 | 17 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 77 | 21 |
| Estradiol | Estradiol | 76 | 14 |
| Montelukast Sodium | Montelukast Sodium | 76 | 15 |
| Lorazepam | Lorazepam | 75 | 15 |
| Atenolol | Atenolol | 72 | 15 |
| Amitriptyline Hcl | Amitriptyline Hcl | 71 | 13 |
| Warfarin Sodium | Warfarin Sodium | 71 | 12 |
| Ventolin Hfa | Albuterol Sulfate | 70 | 20 |
| Buprenorphine Hcl | Buprenorphine Hcl | 68 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 68 | 13 |
| Aripiprazole | Aripiprazole | 65 | 12 |
| Ondansetron Odt | Ondansetron | 64 | 20 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 62 | 16 |
| Ozempic | Semaglutide | 61 | 18 |
| Azithromycin | Azithromycin | 60 | 50 |
| Trulicity | Dulaglutide | 59 | 12 |
| Simvastatin | Simvastatin | 58 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 58 | suppressed |
| Allopurinol | Allopurinol | 57 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 57 | 13 |
| Levetiracetam | Levetiracetam | 57 | suppressed |
| Baclofen | Baclofen | 56 | suppressed |
| Glipizide | Glipizide | 56 | 13 |
| Buspirone Hcl | Buspirone Hcl | 55 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 55 | suppressed |
| Topiramate | Topiramate | 55 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 54 | 40 |
| Diclofenac Sodium | Diclofenac Sodium | 54 | 12 |
| Ketoconazole | Ketoconazole | 54 | 21 |
| Famotidine | Famotidine | 52 | 17 |
| Pregabalin | Pregabalin | 52 | 13 |
| Sucralfate | Sucralfate | 52 | 15 |
| Hydralazine Hcl | Hydralazine Hcl | 50 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 49 | 18 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 49 | 38 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 47 | 18 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 47 | suppressed |
| Diazepam | Diazepam | 46 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 45 | 13 |
| Olanzapine | Olanzapine | 45 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 44 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 44 | suppressed |
| Levofloxacin | Levofloxacin | 44 | 24 |
| Bupropion Xl | Bupropion Hcl | 43 | 13 |
| Lovastatin | Lovastatin | 43 | 11 |
| Fluconazole | Fluconazole | 42 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 42 | suppressed |
| Nitroglycerin | Nitroglycerin | 40 | 30 |
| Paroxetine Hcl | Paroxetine Hcl | 40 | suppressed |
| Jardiance | Empagliflozin | 39 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 39 | 13 |
| Eszopiclone | Eszopiclone | 38 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 38 | 17 |
| Torsemide | Torsemide | 38 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 37 | suppressed |
| Digoxin | Digoxin | 37 | suppressed |
| Glimepiride | Glimepiride | 36 | suppressed |
| Linzess | Linaclotide | 35 | 12 |
| Carisoprodol | Carisoprodol | 34 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 34 | suppressed |
| Methocarbamol | Methocarbamol | 33 | suppressed |
| Januvia | Sitagliptin Phosphate | 32 | suppressed |
| Mirtazapine | Mirtazapine | 32 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 32 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 31 | suppressed |
| Nabumetone | Nabumetone | 31 | suppressed |
| Celecoxib | Celecoxib | 30 | suppressed |
| Constulose | Lactulose | 30 | suppressed |
| Sotalol | Sotalol Hcl | 30 | suppressed |
| Synthroid | Levothyroxine Sodium | 30 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Memantine Hcl | Memantine Hcl | 29 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 28 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 26 | 21 |
| Metformin Hcl Er | Metformin Hcl | 26 | suppressed |
| Xarelto | Rivaroxaban | 26 | suppressed |
| Carbamazepine | Carbamazepine | 25 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 25 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 25 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 25 | suppressed |
| Lamotrigine | Lamotrigine | 25 | suppressed |
| Phenobarbital | Phenobarbital | 25 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 25 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 25 | suppressed |
| Carbamazepine Er | Carbamazepine | 24 | suppressed |
| Novolog Flexpen | Insulin Aspart | 24 | suppressed |
| Cephalexin | Cephalexin | 23 | 22 |
| Lidocaine | Lidocaine | 23 | suppressed |
| Naproxen | Naproxen | 23 | suppressed |
| Novolog | Insulin Aspart | 23 | suppressed |
| Ramipril | Ramipril | 23 | suppressed |
| Colchicine | Colchicine | 22 | 11 |
| Valsartan | Valsartan | 22 | suppressed |
| Verapamil Er | Verapamil Hcl | 22 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 21 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 21 | suppressed |
| Novolin R | Insulin Regular, Human | 21 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 20 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 20 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 20 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 20 | suppressed |
| Acyclovir | Acyclovir | 19 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 19 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 19 | suppressed |
| Movantik | Naloxegol Oxalate | 19 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 18 | 14 |
| Clindamycin Hcl | Clindamycin Hcl | 18 | 12 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 18 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 17 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 17 | suppressed |
| Cilostazol | Cilostazol | 16 | suppressed |
| Myrbetriq | Mirabegron | 16 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 16 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 15 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 15 | suppressed |
| Fentanyl | Fentanyl | 15 | suppressed |
| Ibu | Ibuprofen | 15 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 15 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 15 | 13 |
| Sildenafil Citrate | Sildenafil Citrate | 15 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 15 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Haloperidol | Haloperidol | 14 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 14 | suppressed |
| Lacosamide | Lacosamide | 14 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 14 | suppressed |
| Repatha Syringe | Evolocumab | 14 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 13 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 13 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 13 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 13 | suppressed |
| Victoza 3-Pak | Liraglutide | 13 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 12 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Febuxostat | Febuxostat | 12 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Ibuprofen | Ibuprofen | 12 | suppressed |
| Loxapine | Loxapine Succinate | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Otezla | Apremilast | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Admelog Solostar | Insulin Lispro | 11 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $35.57 · 2 records | Abbott Laboratories | FREESTYLE LIBRE 3, OTEZLA, REPATHA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Otezla play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Amgen Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error